The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.

This study suggests that younger age and pergolide use may be the new associated factors with ICB persistence and that entacapone, zonisamide, and istradefylline use may be associated with the development of ICB. Drug profiles and medication practices in Japan may explain the association of these factors with ICB.